Milestone Pharmaceuticals Inc. - Common Shares Action · CA59935V1076 · MIST (XNAS) — cotations en temps réel, données d'entreprise, dividendes, fondamentaux et analyse de portefeuille IA sur MoneyPeak

Aperçu

Analyse alimentée par l’IA

Analyse fondamentale

Découvrez ce que disent vraiment les chiffres — avant le marché

Analyser maintenant

Sentiment des actualités

Les actualités d’aujourd’hui sont-elles un signal d’achat ou un avertissement ?

Analyser maintenant

Acheter / Conserver / Vendre

Faut-il acheter, conserver ou vendre ? Obtenez l’avis de l’IA dès maintenant.

Analyser maintenant

Évaluation des risques

Détectez les risques cachés avant qu’ils n’impactent votre portefeuille.

Analyser maintenant

Juste valeur

Cette action est-elle bon marché, correctement valorisée ou surévaluée ?

Analyser maintenant

Latest AI Analyses of Milestone Pharmaceuticals Inc. - Common Shares

No Price

01.05.2026 23:59

Current Prices from Milestone Pharmaceuticals Inc. - Common Shares

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	MIST	USD	01.05.2026 23:59	1,89 USD	0,09 USD +5,01 %
IEX	MIST	USD	01.05.2026 19:59	1,87 USD	0,06 USD +3,61 %

Company Profile for Milestone Pharmaceuticals Inc. - Common Shares Share

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

Company Data

Name Milestone Pharmaceuticals Inc. - Common Shares

Company Milestone Pharmaceuticals Inc.

Symbol MIST

Website https://www.milestonepharma.com

Primary Exchange

NASDAQ

ISIN CA59935V1076

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Joseph G. Oliveto

Market Capitalization 161 Mio

Country Canada

Currency USD

Employees 0,0 T

Address 1111 Dr. Frederik-Philips Boulevard, H4M 2X6 Montreal

IPO Date 2019-05-09

Ticker Symbols

Name	Symbol
NASDAQ	MIST

More Shares

Investors who hold Milestone Pharmaceuticals Inc. - Common Shares also have the following shares in their portfolio:

BARRICK N.A.FIN.2043 Bond

MORGAN STANLEY 16/26MTN F Bond